Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment
Jennifer E. Klomp, Ye S. Lee, Craig M. Goodwin, et al.
Cell Reports (2021) Vol. 37, Iss. 9, pp. 110060-110060
Open Access | Times Cited: 24

Showing 24 citing articles:

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer
Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp, et al.
Cancer Research (2022) Vol. 83, Iss. 1, pp. 141-157
Open Access | Times Cited: 69
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Jeffrey A. Klomp, Jennifer E. Klomp, Clint A. Stalnecker, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 23
Combinatorial strategies to target RAS-driven cancers
Naiara Perurena, Lisa Situ, Karen Cichowski
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 316-337
Closed Access | Times Cited: 18
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Jennifer E. Klomp, J. Nathaniel Diehl, Jeffrey A. Klomp, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 16
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Johanna Zerbib, Marica Rosaria Ippolito, Yonatan Eliezer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status
Маргарита Пустовалова, Taisia Blokhina, Lina Alhaddad, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4922-4922
Open Access | Times Cited: 26
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Johanna Zerbib, Marica Rosaria Ippolito, Yonatan Eliezer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 18
Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer
Fangyan Gao, Yueyao Wu, Runtian Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2685-2697
Open Access | Times Cited: 5
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
Zhong-Chen Li, Jie Wang, He-Bin Liu, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113877-113877
Open Access | Times Cited: 4
Inactivation of the TGF-β1/ALK5 axis enhances club cell function and alleviates lung tissue damage to ameliorate COPD progression through the MEK/ERK signaling pathway
Jing Tian, Hui Ouyang, Jie Wu, et al.
General Physiology and Biophysics (2024) Vol. 43, Iss. 01, pp. 37-48
Open Access | Times Cited: 2
CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research
Xian Gong, Jianting Du, Ren‐Wang Peng, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 460-460
Open Access | Times Cited: 2
Undiagnosed RASopathies in infertile men
Anna-Grete Juchnewitsch, Kristjan Pomm, Avirup Dutta, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
Arata Nishimoto
World Journal of Gastroenterology (2022) Vol. 28, Iss. 28, pp. 3637-3643
Open Access | Times Cited: 12
Gemcitabine promotes autophagy and lysosomal function through ERK- and TFEB-dependent mechanisms
Benoît Marchand, Marc-Antoine Poulin, Christine Lawson, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy
Mingming Xiao, H. J. Yang, Mingwei Dong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 1
Methylation of
Fengna Liu, Aiai Gao, Meiying Zhang, et al.
PubMed (2024) Vol. 12, Iss. 3, pp. 274-287
Closed Access | Times Cited: 1
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives
Mahmoud Toulany
Clinical and Translational Radiation Oncology (2022) Vol. 38, pp. 6-14
Open Access | Times Cited: 7
Molecular docking/dynamic simulations, MEP, ADME-TOX-based analysis of xanthone derivatives as CHK1 inhibitors
Ahlem Belkadi, Samir Kenouche, Nadjib Melkemi, et al.
Structural Chemistry (2022) Vol. 33, Iss. 3, pp. 833-858
Closed Access | Times Cited: 6
Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy
Wei Wang, Yue Sun, Xiaobo Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation
Dafei Xie, Qi Huang, Ping‐Kun Zhou
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7656-7656
Open Access | Times Cited: 2
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer
Ye S. Lee, Jennifer E. Klomp, Clint A. Stalnecker, et al.
Genes & Cancer (2023) Vol. 14, pp. 30-49
Open Access | Times Cited: 2
Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding?
Ekaterina Shevchenko, Tatu Pantsar
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 633-648
Open Access | Times Cited: 4
The role of AMPK in pancreatic cancer: from carcinogenesis to treatment
Shahrzad Shahrokhi Nejad, Sepideh Razi, Nima Rezaei
Clinical & Translational Oncology (2024)
Closed Access
The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer
Ching‐Feng Chiu, Huiru Lin, Yen‐Hao Su, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11797-11797
Open Access
Page 1

Scroll to top